Baxter to Present at Jefferies London Healthcare Conference
Get Alerts BAX Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 0.2%
EPS Growth %: -37.3%
Join SI Premium – FREE
DEERFIELD, Ill.--(BUSINESS WIRE)-- Baxter International Inc. (NYSE: BAX), a global medtech leader, will present at the Jefferies London Healthcare Conference on Wednesday, November 20, 2024. Joel Grade, Baxter’s chief financial officer, is scheduled to present at 11:00 a.m. Greenwich Mean Time.
The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay through Monday, May 19, 2025.
About Baxter
Every day, millions of patients and caregivers rely on Baxter’s leading portfolio of diagnostic, critical care, kidney care, nutrition, hospital and surgical products used across patient homes, hospitals, physician offices and other sites of care. For more than 90 years, we’ve been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. With products, digital health solutions and therapies available in more than 100 countries, Baxter’s employees worldwide are now building upon the company’s rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations. To learn more, visit www.baxter.com and follow us on X, LinkedIn and Facebook.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241113286641/en/
Media Contact
Steve Brett, (224) 948-5353
[email protected]
Investor Contact
Clare Trachtman, (224) 948-3020
Source: Baxter International Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Iceotope Wins Best HPC Cooling Innovation at the 2026 Nimbus Innovation Awards
- Prepayments (CK93) - Nykredit Realkredit A/S
- OLX Group continues strong performance as motors, real estate and jobs drive growth
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share